Unknown

Dataset Information

0

Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer.


ABSTRACT:

Background

Identification of biomarkers associated with benefit of adjuvant chemotherapy in stage II/III colon cancer is an important task.

Methods

Vessel density (VD) and tumour stroma were analysed in a randomised-trial-derived discovery cohort (n = 312) and in a stage II/III group of a population-based validation cohort (n = 85). VD was scored separately in the tumour centre, invasive margin and peritumoral stroma compartments and quantitated as VD/total analysed tissue area or VD/stroma area.

Results

High stroma-normalised VD in the invasive margin was associated with significantly longer time to recurrence and overall survival (OS) (p = 0.002 and p = 0.006, respectively) in adjuvant-treated patients of the discovery cohort, but not in surgery-only patients. Stroma-normalised VD in the invasive margin and treatment effect were significantly associated according to a formal interaction test (p = 0.009). Similarly, in the validation cohort, high stroma-normalised VD was associated with OS in adjuvant-treated patients, although statistical significance was not reached (p = 0.051).

Conclusion

Through the use of novel digitally scored vessel-density-related metrics, this exploratory study identifies stroma-normalised VD in the invasive margin as a candidate marker for benefit of adjuvant 5-FU-based chemotherapy in stage II/III colon cancer. The findings, indicating particular importance of vessels in the invasive margin, also suggest biological mechanisms for further exploration.

SUBMITTER: Mezheyeuski A 

PROVIDER: S-EPMC6738077 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer.

Mezheyeuski Artur A   Hrynchyk Ina I   Herrera Mercedes M   Karlberg Mia M   Osterman Eric E   Ragnhammar Peter P   Edler David D   Portyanko Anna A   Ponten Fredrik F   Sjöblom Tobias T   Glimelius Bengt B   Östman Arne A  

British journal of cancer 20190710 4


<h4>Background</h4>Identification of biomarkers associated with benefit of adjuvant chemotherapy in stage II/III colon cancer is an important task.<h4>Methods</h4>Vessel density (VD) and tumour stroma were analysed in a randomised-trial-derived discovery cohort (n = 312) and in a stage II/III group of a population-based validation cohort (n = 85). VD was scored separately in the tumour centre, invasive margin and peritumoral stroma compartments and quantitated as VD/total analysed tissue area or  ...[more]

Similar Datasets

| S-EPMC4563117 | biostudies-literature
| S-EPMC6048031 | biostudies-literature
| S-EPMC7077592 | biostudies-literature
2024-07-10 | GSE250057 | GEO
| S-EPMC11578081 | biostudies-literature
| S-EPMC6802034 | biostudies-literature
| S-EPMC9384943 | biostudies-literature
| S-EPMC8104207 | biostudies-literature
| S-EPMC6426127 | biostudies-literature
| S-EPMC5123629 | biostudies-literature